Recommended

FDA tightens COVID vaccine use
Decentralised manufacturing consortium launched
Trial boost for myasthenia gravis drug
FDA starts publishing daily AE data
WEBINAR | The Future of Sterility Testing: One-Day Results with Advanced RT-rt PCR Technology | 5 NOV
WEBINAR | Mastering Impurity Profiling: USP’s Evolving Standards and Strategies | 15 OCT
news

Aseptic packaging market to value $35bn by 2033

1
SHARES

Factors contributing to the growth of the aseptic packaging market include a rising demand for biologics and vaccines and greater focus on sustainability, a report states.

Aseptic packaging market to value $35 billion by 2033

According to a report by Research Nester, the global aseptic packaging market is projected to reach a revenue of $35 billion by 2033 and is estimated to reach a compound annual growth rate (CAGR) of 10 percent between 2023 and 2033.

 

ACCESS your FREE COPY

 


This report addresses the key factors shaping pharmaceutical formulation, including regulation, QC and analysis.

Access the full report now to discover the techniques, tools and innovations that are transforming pharmaceutical formulation, and learn how to position your organisation for long-term success.

What you’ll discover:

  • Key trends shaping the pharmaceutical formulation sector
  • Innovations leading progress in pharmaceutical formulation and how senior professionals can harness their benefits
  • Considerations and best practices when utilising QbD during formulation of oral solid dosage forms
  • And more!

Don’t miss your chance to access this exclusive report ! Access now – it’s free

Aseptic packaging eliminates the necessity for preservatives and refrigeration which is especially advantageous for medications and vaccines that are sensitive to temperature changes.

Aseptic packaging has vastly improved the stability and safety of medications, as it provides benefits such as drug stability and more efficient distribution methods.

Examples of aseptic packaging in the pharmaceutical industry include pre-filled syringes, IV bags, vials and ampoules, freeze-drying, lyophilisation and blow-fill-seal (BFS) technology.

Growth of the European aseptic packaging market

The pharmaceutical industry in Europe is witnessing growth in the market for aseptic packaging. Research Nester highlighted statistics which acknowledged that European production of pharmaceutical aseptic packaging is expected to reach $56 billion by 2026.

According to the report, European production has grown by approximately 5.4 percent annually in recent years. Contributing factors include a rising demand for biologics and vaccines and advancements in pharmaceutical R&D. For example, Statista stated earlier this year that Roche invested around $14 billion in R&D in 2022, making it a leader in R&D spending last year.

Additionally, the report noted that with the focus of sustainability becoming increasingly prevalent worldwide, aseptic packaging is particularly appealing because it is considered eco-friendly, as the materials used to make these packages come from various renewable sources. This aligns with Europe’s efforts to reduce waste and energy usage.

Technology advancement and pharmaceutical packaging

A paper published in Pharmaceutics also described how technology will, in the coming years, bring about a widespread adoption of robots in aseptic manufacturing environments. Not only could advanced technologies be beneficial in final packaging, but it could be advantageous across the entire production chain, including the filling stage.

Share via
Share via